Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
20
NMPA:20
Drug Approvals
Pyridostigmine Bromide Tablets
- Product Name
- 溴吡斯的明片
- Approval Number
- 国药准字H20143421
- Approval Date
- Jul 4, 2024
NMPA
Guaifenesin，Methylephedrine Hydrochloride and Chlorphenamine Maleate Granules
- Product Name
- 愈酚甲麻那敏颗粒
- Approval Number
- 国药准字H20090097
- Approval Date
- Aug 15, 2023
NMPA
Calcium Dobesilate Granules
- Product Name
- 羟苯磺酸钙颗粒
- Approval Number
- 国药准字H20080727
- Approval Date
- May 4, 2023
NMPA
Terbinafine Hydrochloride Cream
- Product Name
- 盐酸特比萘芬乳膏
- Approval Number
- 国药准字H20083268
- Approval Date
- Feb 21, 2023
NMPA
Compound Diisopropropylammonium Dichloroacetate Tablets
- Product Name
- 复方二氯醋酸二异丙胺片
- Approval Number
- 国药准字H20093157
- Approval Date
- Feb 20, 2023
NMPA
Terbinafine Hydrochloride Cream
- Product Name
- 盐酸特比萘芬乳膏
- Approval Number
- 国药准字H20083267
- Approval Date
- Oct 17, 2022
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found